Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL3630519 | 1.00 | — | — | |
| Acetic Acid SCHEMBL28364497 | 1.00 | FFAR3 (0.78) | — | |
| Acetic Acid SCHEMBL27879756 | 1.00 | FFAR3 (0.78) | — | |
| Acetic Acid SCHEMBL28211308 | 1.00 | — | — | |
| Acetic Acid SCHEMBL28942881 | 1.00 | FFAR3 (0.78) | — | |
| Acetic Acid SCHEMBL19285650 | 1.00 | FFAR3 (0.78) | — | |
| Acetic Acid SCHEMBL7592578 | 0.95 | FFAR3 (0.70) | — | |
| Acetic Acid SCHEMBL20137312 | 0.95 | FFAR3 (0.70) | — | |
| Acetic Acid SCHEMBL449429 | 0.95 | — | — | |
| Acetic Acid SCHEMBL28229072 | 0.95 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119595804-A | Method for detecting content of heparin precursor and application thereof | 深圳市天道医药有限公司 | 2025-03-11 | — | — | CN | claimed |
| CN-109613157-A | A kind of raw material heparin sodium for producing Enoxaparin Sodium and using | 山东万邦赛诺康生化制药股份有限公司 | 2019-04-12 | — | — | CN | claimed |
| CN-1753624-B | Method for reducing acrylamide formation in thermally processed foods | FRITO LAY NORTH AMERICA INC FO | 2010-05-12 | — | — | CN | claimed |
| CN-1753624-A | Method for reducing acrylamide formation in thermally processed foods | FRITO LAY NORTH AMERICA INC FO (US) | 2006-03-29 | — | — | CN | claimed |
| CN-116218827-B | Heparanase mutant and recombinant expression method and application thereof | 深圳大学 | 2025-06-24 | — | — | CN | disclosed |
| CN-116256455-B | Method for identifying bovine pulmonary heparin doping content in porcine intestinal mucosa derived heparin | 东营天东制药有限公司 | 2025-05-30 | — | — | CN | disclosed |
| CN-119595804-A | Method for detecting content of heparin precursor and application thereof | 深圳市天道医药有限公司 | 2025-03-11 | — | — | CN | disclosed |
| CN-115927277-B | Heparanase mutant H1-6 and engineering strain and application thereof | 深圳大学 | 2025-02-11 | — | — | CN | disclosed |
| CN-115851669-B | Heparanase mutant H1-5 and encoding gene, mutant strain and application thereof | 深圳大学 | 2024-10-01 | — | — | CN | disclosed |
| CN-116218826-B | Heparanase mutant H2-15 and engineering strain and application thereof | 深圳大学 | 2024-10-01 | — | — | CN | disclosed |
| CN-116577428-A | Method for detecting enoxaparin sodium heparinase II enzymatic hydrolysis component | 东营天东制药有限公司 | 2023-08-11 | — | — | CN | disclosed |
| CN-116256455-A | Method for identifying bovine pulmonary heparin doping content in porcine intestinal mucosa derived heparin | 东营天东制药有限公司 | 2023-06-13 | — | — | CN | disclosed |
| CN-109613157-A | A kind of raw material heparin sodium for producing Enoxaparin Sodium and using | 山东万邦赛诺康生化制药股份有限公司 | 2019-04-12 | — | — | CN | disclosed |
| CN-107468644-A | A kind of levo-oxiracetam injection and preparation method thereof | 重庆润泽医药有限公司 | 2017-12-15 | — | — | CN | disclosed |
| CN-107028897-A | Immunomodulator thymopeptide-5 powder-injection pharmaceutical composition and quality control method | 北京元延医药科技股份有限公司 | 2017-08-11 | — | — | CN | disclosed |
| CN-102743379-B | Composition containing eighteen amino acids and preparation method thereof | LI HUI | 2013-07-31 | — | — | CN | disclosed |
| CN-102743379-A | Composition containing eighteen amino acids | LI HUI | 2012-10-24 | — | — | CN | disclosed |
| CN-1753624-B | Method for reducing acrylamide formation in thermally processed foods | FRITO LAY NORTH AMERICA INC FO | 2010-05-12 | — | — | CN | disclosed |
| US-20070105944-A1 | Taxane metabolites | COMEZOGLU S N | 2007-05-10 | — | — | US | disclosed |
| CN-1753624-A | Method for reducing acrylamide formation in thermally processed foods | FRITO LAY NORTH AMERICA INC FO (US) | 2006-03-29 | — | — | CN | disclosed |